ONAMPI Trademark

Trademark Overview

On Monday, December 22, 2014, a trademark application was filed for ONAMPI with the United States Patent and Trademark Office. The USPTO has given the ONAMPI trademark a serial number of 86487815. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 5, 2022. This trademark is owned by AstraZeneca AB. The ONAMPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
onampi

General Information

Serial Number86487815
Word MarkONAMPI
Filing DateMonday, December 22, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 5, 2022
Registration Number4891596
Registration DateTuesday, January 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, August 5, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 26, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 8, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, October 6, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, September 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 13, 2015ASSIGNED TO LIE
Thursday, August 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 31, 2015ASSIGNED TO EXAMINER
Tuesday, December 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 25, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

onampi diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal